Abstract
The treatment of the Gilles de la Tourette syndrome has evolved from case reports, clinical experience and more recently blinded trials usually in small numbers of patients. We have reviewed the evidence available to clinicians. The oldest and still most widely prescribed drug, haloperidol, should now not be considered the firstline agent in children as other agents have superior adverse effects profiles. Symptomatic treatment should be targeted to the specific additional psychopathologies seen in the syndrome. For the treatment of tics, sulpiride, tiapride, possibly pimozide and in some cases clonidine may be considered first-line agents. Although a body of data supports pimozide, caution has to be exercised in relation to possible cardiac effects. Antidepressants and stimulants have an important place in the management of depression, obsessionality and attention deficit hyperactivity disorder. The latter also responds to clonidine making it a rational first choice where ADHD coexists with GTS. There are a multitude of other drugs advocated in the literature in addition to reports of neurosurgery and the novel use of immune modulation. Therapeutic trials for GTS are challenging. However, further data from blinded trials are required before many of these treatments can be considered to be mainstream treatment options.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Abe K, Oda N (1978) Follow-up study of children of childhood tiquers. Biological Psychiatry 13: 629–630
Abwender DA, Como PG, Kurlan R, Parry K, Fett KA, Cui L, Plumb S, Deely C (1996) School problems in Tourette’s syndrome. Archives of Neurology 53: 509–11
Ahmed I, Dagincourt PG, Miller LG, Shader RI (1993) Possible interaction between fluoxetine and pimozide causing sinus bradycardia. Canadian Journal of Psychiatry 38: 62–3
Alessi NE, Walden M, Hsieh PS (1989) Nifedipine-haloperidol combination in the treatment of Gilles de la Tourette’s syndrome: a case study. Journal of Clinical Psychiatry 50: 103–4
American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental disorders (Third edition revised) (DSM-III-R). Washington DC: American Psychiatric Association
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental disorders (Fourth edition) (DSMIV). Washington DC: American Psychiatric Association
Apter A, Pauls DL, Bleich A, Zohar AH, Kron S, Ratzoni G (1993) An epidemiological study of Gilles de la Tourette’s syndrome in Israel. Archives of General Psychiatry 50: 734–738
Azrin NH, Peterson NL (1988) Habit reversal for the treatment of Tourette syndrome. Behaviour Research and Therapy 26: 347–51
Baron M, Shapiro E, Shapiro AK, Rainer JD (1981) Genetic analysis of Tourette syndrome suggesting major gene effect. American Journal of Human Genetics 33: 767–775
Berg R (1985) A case of Tourette syndrome treated with nifedipine. Acta Psychiatrica Scandinavica 72: 400–1
Bergin A, Waranch HR, Brown J, Carson K, Singer HS (1998) Relaxation therapy in Tourette syndrome: a pilot study. Pediatric Neurology 18: 136–42
Berkson J (1946) Limitations of the application of fourfold table analysis to hospital data. Biometrics 2: 47–51
Bhadrinah BR (1998) Olanzepine in Tourette syndrome (letter). British Journal of Psychiatry 172: 366
Bhatia MS, Balkrishna, Singhal PK, Kaur N (1989) Tourette syndrome treated with nifedipine. Indian Journal of Pediatrics 56: 300–1
Borrison RL, Ang L, Hamilton WJ, Diamond BI Davis JM (1983) Treatment approaches in Gilles de la Tourette syndrome. Brain Research Bulletin 11: 205–8
Bouchard RH, Pourcher E, Vincent P (1990) Fluoxetine and extrapyramidal side effects. American Journal of Psychiatry 146: 1352–2
Bruun RD (1984) Gilles de la Tourette’s syndrome: an overview of clinical experience. Journal of the American Academy of Child and Adolescent Psychiatry 23: 126–133
Bruun RD (1988) Subtle and underrecognised side effects of neuroleptic treatment in children with Tourette’s disorder. American Journal of Psychiatry 145: 621–4
Bruun RD, Budman CL (1996) Risperidone as a treatment for Tourette’s syndrome. Journal of Clinical Psychiatry 57: 29–31
Budman CL, Kerjakovic M, Bruun R (1997) Viral infection and tic exacerbation (letter). Journal of the American Academy of Child and Adolescent Psychiatry 36: 162
Burd L, Kerbeshian J (1987) Treatmentgenerated problems associated with behavior modification in Tourette disorder. Developmental Medicine and Child Neurology 29: 831–3
Caine ED, Polinsky RJ, Kartinel R, Ebert MH (1979) The trial use of clozapine for abnormal involuntary movement disorders. American Journal of Psychiatry 136: 317–20
Canavan AG, Powell GE (1981) The efficacy of several treatments of Gilles de la Tourette’s syndrome as assessed in a single case. Behaviour Research and Therapy 19: 549–56
Castellanos FX, Giedd JN, Elia J, Marsh WL, Ritchie GF, Hamburger SD (1997) Controlled stimulant treatment of ADHD and comorbid Tourette’s syndrome: effects of stimulant and dose. Journal of the American Academy of Child and Adolescent Psychiatry 34: 1140–6
Chappell PB, Riddle MA, Scahill L, Lynck KA, Schultz R, Arnsten A, Leckman JF, Cohen DJ (1995) Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette’s syndrome: preliminary clinical experience. Journal of the American Academy of Child and Adolescent Psychiatry 34: 1140–6
Clark DF (1970) Behavioral approaches to treatment of Gilles de la Tourette’s syndrome. New York State Journal of Medicine 70: 2205–10
Clarke DJ, Ford R (1988) Treatment of refractory Tourette syndrome with haloperidol decanoate. Acta Psychiatrica Scandinavica 77: 495–6
Clomipramine Collaborative Study Group (1991) Clomipramine in the treatment of patients with obsessive-compulsive disorders. Archives of General Psychiatry 48: 730–8
Cohen DJ, Detlor J, Young DJ, Shaywitz BA (1980) Clonidine ameliorates Gilles de la Tourette’s syndrome. Archives of General Psychiatry 37: 1350
Comings DE & Comings BG (1987) A controlled study of Tourette Syndrome: 1. Attention deficit disorder, learning disorders and school problems. American Journal of Human Genetics 41: 701–741
Comings DE, Hines JA, Comings BG (1990) An epidemiologic study of Tourette’s syndrome in a single school district. Journal of Clinical Psychiatry 51: 563–569
Comings DE, Wu S, Chiu C, Ring Rh, Gade R, Ahn C, MacMurray JP, Dietz G, Muhleman D (1996) Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of three dopaminergic genes — DRD2, DBetaH, DAT1. American Journal of Medical Genetics 67: 264–288
Costello EJ, Angold A, Burns BJ, Stangl DK, Tweed DL, Erkanli A, Worthman CM (1996) The Great Smoky Mountains Study of Youth. Goals, design, methods, and the prevalence of DSM-111-R Disorders. Archives of General Psychiatry 53: 1129–1136
Curtis D, Robertson MM, Gurling HM (1992) Autosomal dominant gene transmission in a large kindred with Gilles de la Tourette syndrome. British Journal of Psychiatry 160: 845–849
De Groot CM, Janus MD, Bornstein RA (1995) Clinical predictors of psychopathology in children and adolescents with Tourette Syndrome. Journal of Psychiatric Research 29: 59–70
Delgado PL, Goodman WK, Price LH, Heninger GR, Charney DS (1990) Fluvoxamine/pimozide treatment of concurrent Tourette’s and obsessive-compulsive disorder. British Journal of Psychiatry 157: 762–5
DiGiacomo JN, Fahn S, Glass JB, Westlake RJ (1971) A case with Gilles de la Tourette’s syndrome: recurrent refractoriness to haloperidol, and unsuccessful treatment with L-dopa. Journal of Nervous and Mental Disease 152: 115–7
Dillon DC, Salzman IJ, Schusinger DA (1985) The use of imipramine in Tourette’s syndrome and attention deficit disorder: case report. Journal of Clinical Psychiatry 46: 348–9
Donahoe Meador M, Fortune T, Llorena R (1991) Tourette’s syndrome and treatment with Clomipramine hydrochloride. West Virginia Medical Journal 87: 468–70
Drtikova I, Balatikova B, Lemonova H, Zak J (1996) Therapeutic effects of clonazepam in children with tic syndrome. Homeostasis Health and Disease 37: 216
Dursun SM, Revely MA (1997) Differential effects of transdermal nicotine on microstructured analyses of tics in Tourette’s syndrome: an open study. Psychological Medicine 27: 483–487
Eapen V, Katona CLE, Barnes TRE, Robertson MM (1993) Sulpiride induced tardive dyskinesia in a person with Gilles de la Tourette syndrome. Journal of Psychopharmacology 7: 290–2
Eapen V, Pauls DL, Robertson MM (1993) Evidence for autosomal dominant transmission in Gilles de la Tourette syndrome — United Kingdom cohort. British journal of Psychiatry 162: 593–596
Eapen V, Robertson MM (1994) All that tics may not be Tourette’s. British Journal of Psychiatry 164: 708 (letter)
Eapen V, Trimble MR, Robertson MM (1996) The use of fluoxetine in Gilles de la Tourette syndrome and obsessive compulsive behaviours: preliminary clinical experience. Progress in Neuro-psychopharmacology and Biological Psychiatry 20: 737–43
Eapen V, Robertson MM, Zeitlin H, Kurlan R (1997) Gilles de la Tourette’s syndrome in special education schools: a United Kingdom study. Journal of Neurology 244: 378–382
Eapen V, Robertson MM, Alsobrook JP, Pauls DL (1997) Obsessive compulsive symptoms in Gilles de la Tourette syndrome and obsessive compulsive disorder: differences by diagnosis and family history. American Journal of Medical Genetics 74: 432–438
Eapen V, O’Niell J, Gurling HMD, Robertson MM (1997) Sex of parent transmission effect in Tourette’s syndrome: evidence for earlier age at onset in maternally transmitted cases suggests a genomic imprinting effect. Neurology 48: 934–937
Eggers C, Rothenberger A, Berghaus U (1988) Clinical and neurobiological findings in children suffering from tic disease following treatment with tiapride. European Archives of Psychiatry and Neurological Sciences 237: 223–9
Erenberg G, Cruse RP, Rothner AD (1986) Tourette syndrome: an analysis of 200 pediatric and adolescent cases. Cleveland Clinic quarterly 53: 127–131
Erickson HM, Goggin JE, Messiha FS (1977) Comparison of lithium and haloperidol therapy in Gilles de la Tourette syndrome. Advances in Experimental Medicine and Biology 90: 197–205
Fallon T Jr, Schwab-Stone M (1992) Methodology of epidemiological studies of tic disorders and comorbid psychopathology. In: Chase TN, Friedhoff AJ, Cohen DJ (eds) Tourette Syndrome; Genetics, Neurobiology and Treatment. Adv Neurol, 58. New York: Raven Press, pp 43–53
Feigin A, Kurlan R, McDermott MP, Beach J, Dimitsopulos T, Brower CA, Chapieski L, Trinidad K, Como P, Jankovic J (1996) A controlled trial of deprenyl in children with Tourette’s syndrome and attention deficit hyperactivity disorder. Neurology 46: 965–8
Fennig S, Fennig SN, Pato M, Weitzman A (1994) Emergence of symptoms of Tourette’s syndrome during fluvoxamine treatment of obsessive-compulsive disorder. British Journal of Psychiatry 164: 839–41
Ferrari M, Matthews WS, Barabas G (1984) Children with Tourette syndrome; results of psychological tests given prior to drug treatment. Developmental and Behavioral Pediatrics 5: 116–119
Frankel M, Cummings JL, Robertson MM, Trimble MR, Hill MA, Benson DF (1986) Obsessions and compulsions in Gilles de la Tourette’s syndrome. Neurology 36: 378–381
Fulop G, Phillips RA, Shapiro AK, Gomes JA, Shapiro E, Nordlie JW (1987) ECG changes during haloperidol and pimozide treatment of Tourette’s disorder. American Journal of Psychiatry 144: 673–5
Gadow KD, Sverd J, Nolan EE (1992) Methylphenidate in hyperactive boys with comorbid tic disorder: II Short-term behavioral effects in school settings. Journal of the American Academy of Child and Adolescent Psychiatry 31: 462–71
Gadow KD, Sverd J, Sprafkin J, Nolan EE, Ezor SN (1995) Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder. Archives of General Psychiatry 52: 444–55
Gancher S, Conant-Norville D, Angell R (1990) Treatment of Tourette’s syndrome with transdermal clonidine: a pilot study. Journal of Neuropsychiatry and Clinical Neuroscience 2: 66–9
George MS, Trimble MR, Robertson MM (1993) Fluvoxamine and sulpiride in comorbid obsessive-compulsive disorder and Gilles de la Tourette syndrome. Human Psychopharmacology 8: 327–34
Goetz CG, Tanner CM, Wilson RS, Caroll VS, Como PG, Shannon KM (1987) Clonidine and Gilles de la Tourette’s syndrome: double-blind study using objective rating methods. Annals of Neurology 21: 307–10
Goldstein JA (1984) Nifedipine treatment of Tourette’s syndrome (letter). Journal of Clinical Psychiatry 45: 360
Griesemer DA (1997) Pergolide in the management of Tourette syndrome. Journal of Child Neurology 12: 402–3
Hasstedt SJ, Leppert M, Filloux F, van der Wetering BJM, McMahon WM (1995) Intermediate inheritance of Tourette syndrome, assuming assortive mating. American Journal of Human Genetics 57: 682–689
Healy CE (1970) Gilles de la Tourette’s syndrome (maladie des tics). Successful treatment with haloperidol. American Journal of diseases in children 120: 62–3
Heutink P, Breedveld GJ, Niermeijer MF, van der Wetering BJM, Oostra BA (1993) Progress in gene localization. In: Kurlan R (ed) Handbook of Tourette’s Syndrome and Related Tic and Behavioral Disorders. New York: Marcel Dekker, pp 317–335
Hoge SK, Biederman J (1986) A case of Tourette’s syndrome with symptoms of attention deficit disorder treated with desipramine. Journal of Clinical Psychiatry 47: 478–9
Hollandsworth JG, Bausinger L (1978) Unsuccessful use of massed practice in the treatment of Gilles de la Tourette’s syndrome. Psychological Reports 43: 671–7
Jacobsen FM (1995) Risperidone in the treatment of affective illness and obsessive compulsive disorder. Journal of Clinical Psychiatry 56: 423–9
Jankovic J (1994) Botulinum toxin in the treatment of dystonic tics. Movement Disorders 9: 347–9
Jankovic J, Beech J (1997) Long-term effects of tetrabenazine in hyperkinetic movement disorders. Neurology 48: 358–62
Kellmer Pringle ML, Butler NR, Davie R (1966) 11,000 seven year olds. First report of the National Child Development Study (1958 cohort). Longmans. Green & Co Ltd, London
Kidd KK, Pauls DL (1982) Genetic hypotheses for Tourette syndrome. In: Friedhoff AJ, Chase TN (eds) Gilles de la Tourette Syndrome. Adv Neurol 35, New York: Raven Press, pp 243–249
Kiessling LS, Marcotte AC, Culpepper L (1993) Antineuronal antibodies in movement disorders. Pediatrics 92: 39–43
Kurlan R, Majumdar L, Deeley C, Mudholkar GS, Plumb S, Como PG (1991) A controlled trial of propoxyphene and naltrexone in patients with Tourette’s syndrome. Annals of Neurology 30: 19–23
Kurlan R, Como PG, Deeley C, McDermott M, McDermott MP (1993) A pilot controlled study of fluoxetine for obsessive-compulsive symptoms in children with Tourette’s syndrome. Clinical Neuropharmacology 16: 162–72
Kurlan R, Whitmore D, Irvine C, McDermott MP, Como PG (1994) Tourette’s syndrome in a special education population: a pilot study involving a single school district. Neurology 44: 699–702
Kurlan R, Eapen V, Stern J, McDermott MP, Robertson MM (1994) Bilineal transmission in Tourette syndrome families. Neurology 44: 2236–2242
Kurlan R, Daragjati C, Como PG, McDermott MP, Trinidad KS, Roddy S, Robertson MM (1996) Non-obscene complex socially inappropriate behavior in Tourette’s syndrome. Journal of Neuropsychiatry and Clinical Neurosciences 8: 311–317
Lapouse R, Monk MA (1964) Behavior deviations in a representative sample of children. American Journal of Orthopsychiatry 34: 436–446
Leckman JF, Detlor J, Harcherik DF, Ort S, Shaywitz BA, Cohen DJ (1985) Short- and long-term treatment of Tourette’s syndrome with clonidine: a clinical perspective. Neurology 35: 343–51
Leckman JF, Price RA, Walkup JT, Ort S, Pauls DL, Cohen DJ (1987) Nongenetic factors in Gilles de la Tourette’s syndrome. Archives of General Psychiatry 44: 100
Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KI, Stevenson, Cohen DJ (1989) The Yale Global Tic Severity Scale: initial testing of a clinician rated scale of tic severity. Journal of the American Academy of Child and Adolescent Psychiatry 28: 566–573
Leckman JF, Dolansky ES, Hardin MT (1990) Perinatal factors in the expression of Tourette’s syndrome: an exploratory study. Journal of the American Academy of Child and Adolescent Psychiatry 29: 220–226
Leckman JF, Hardin MT, Riddle MA, Stevenson J, Ort SL, Cohen DJ (1991) Clonidine treatment of Gilles de la Tourette’s syndrome. Archives of General Psychiatry 48: 324–8
Leckman JF, Zhang HP, Vitale A, Lahnin F, Lynch K, Bondi C, Kim YS (1998) Course of tic severity in Tourette syndrome: the first two decades. Pediatrics 102: 14–19
Leonard HL, Lenane MC, Swedo SE, Rettew DC, Gershon ES, Rapoport JL (1992) Tics and Tourette’s Disorder: a 2–7 year follow-up of 54 obsessive-compulsive children. American Journal of Psychiatry 149: 1244–1251
Lipinski JF, Mallya G, Zimmerman P, Pope HG (1989) Fluoxetine-induced akathesia —clinical and theoretical implications. Journal of Clinical Psychiatry 50: 339–42
Lipinski JF, Sallee FR, Jackson C, Sethuraman G (1997) Dopamine agonist treatment of Tourette disorder in children: results of an open-label trial of pergolide. Movement Disorders 12: 402–7
Lipkin PH, Goldstein IJ, Adesman AR (1994) Tics and dyskinesias associated with stimulant treatment in attention-deficit hyperactivity disorder. Archives of Pediatric and Adolescent Medicine 148: 859–861
Lombroso PJ, Scahill L, King RA, Lynch KA, Chapell PB, Peterson BS, McDougle CJ, Leckman JF (1995) Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary report. Journal of the American Academy of Child and Adolescent Psychiatry 34: 1147–52
March JS (1995) Cognitive-behavioral treatments for children and adolescents with OCD: a review and recommendations for treatment. Journal of the American Academy of Child and Adolescent Psychiatry 34: 7–18
Mason A, Banerjee S, Eapen V, Zeitlin H, Robertson MM (1998) The prevalence of Tourette syndrome in a mainstream school population. Developmental Medicine and Child Neurology 40: 292–296
McConville BJ, Sanberg PR, Fogelson MH, King J, Cirino P, Parker KW, Norman AB (1992) The effects of nicotine plus haloperidol compared to nicotine only and placebo nicotine only in reducing tic severity and frequency in Tourette’s disorder. Biological Psychiatry 31: 832–40
McDougle CJ, Goodman WK, Leckman JF, Barr LC, Henninger GR, Price LH (1994) The efficacy of fluvoxamine in OCD: effects of comorbid chronic tic disorder. Journal of Clinical Psychopharmacology 13: 354–8
Mercadante MT, do Rosario Campos MC, Marques-Dias MJ, Miguel EC, Leckman J (1997) Vocal tics in Sydenham’s chorea (letter). Journal of the American Academy of Child and Adolescent Psychiatry 36: 305
Messiha FS (1979) A pharmacotherapeutic rationale for the use of lithium carbonate in Tourette’s syndrome. Proceedings of the Western Pharmacology Society 22: 27–9
Meuldijk R, Colon EJ (1992) Methadone treatment of Tourette’s disorder (letter). American Journal of Psychiatry 149: 139–40
Micheli F, Gatto M, Lekhuniec E, Mangone C, Fernandez Pardal M, Pikielny R, Casas Parera I (1990) Treatment of Tourette’s syndrome with calcium antagonists. Clinical Neuropharmacology 13: 77–83
Michultka DM, Blanchard EB, Rosenblum EL (1989) Stress management and Gilles de la Tourette’s syndrome. Biofeedback and Self Regulation 14: 115–23
Minderaa RB (1987) The treatment of children with Gilles de la Tourette’s syndrome (in Dutch). Tijdschrift voor Kindergeneeskunde 55: 10–15
Moss, DE, Manderscheid PZ, Montgomery Sp, Norman AB, Sanberg PR (1989) Nicotine and cannabinoids as adjuncts to neuroleptics in the treatment of Tourette syndrome and other motor disorders. Life Sciences 44: 1521–5
Muller N (1992) Exacerbation of tics following antidepressant therapy in a case of Gilles de la Tourette syndrome (letter). Pharmacopsychiatry 25: 243–4
Muller N, Riedel M, Erfurth A, Moller HJ (1997) Immunoglobulin therapy in Gilles de la Tourette syndrome (in German). Nervenarzt 68: 914–6
Mullervahl KR, Kolbe H, Dengler R (1997) Gilles de la Tourette syndrome, influence of nicotine, alcohol and marijuana on the clinical symptoms (in German). Nervenarzt 68: 985–9
Mullervahl KR, Kolbe H, Schneider U, Emrich HM (1998) Cannabinoids: possible role in patho-physiology and therapy of Gilles de la Tourette syndrome. Acta Psychiatrica Scandinavica 98: 502–6
Nolan EE, Gadow KD (1997) Children with ADHD and tic disorder and their classmates: behavioral normalization with methylphenidate. Journal of the American Academy of Child and Adolescent Psychiatry 36: 597–604
Packer LE (1997) Social and educational resources for patients with Tourette syndrome. Neurologic Clinics of North America 15: 457–473
Pakstis AJ, Heutink P, Pauls DL, Kurlan R, VanderWetering BJM, Leckamn JF, Sandkuyl JL, Kidd JR, Breedweld GJ, Castiglione CM, Weber J, Sparkes RS, Cohen DJ, Kidd KK, Oostra BA (1991) Progress in the search for genetic linkage with Tourette syndrome: an exclusion map covering more than 50 percent of the autosomal genome. American Journal of Human Genetics 48: 281–294
Paolucci S, Buttinelli C, Fiume S, Ciani S, Lenzi GL (1984) Treatment of Gilles de la Tourette syndrome with depot neuroleptics. Acta Neurologica 6: 222–4
Pauls DL, Hurst CR, Kruger SD, Leckman JF, Kidd KK, Cohen DJ (1986) Gilles de la Tourette’s Syndrome and attention deficit disorder with hyperactivity. Evidence against a genetic relationship. Archives of General Psychiatry 43: 117–1179
Pauls DL, Leckman JF, Cohen DJ (1993) Familial relationship between Gilles de la Tourette’s syndrome, attention deficit disorder, learning disabilities, speech disorders, and stuttering. Journal of the American Academy of Child and Adolescent Psychiatry 32: 1044–1050
Pelham WE, Wheeler T, Chronis A (1988) Empirically supported psychosocial treatments for attention deficit hyperactivity disorder. Journal of Clinical Child psychology 27: 190–205
Peterson AL, Azrin NH (1992) An evaluation of behavioral treatments for Tourette syndrome. Behaviour Research and Therapy 30: 167–74
Peterson BS, Leckman JF, Scahill L, Naftolin F, Keefe D, Charest NJ, King RA, Hardin MT, Cohen DJ (1994) Steroid hormones and Tourette’s syndrome: early experience with antiandrogen therapy. Journal of Clinical Psychopharmacology 14: 131–5
Peterson BS, Zhang H, Anderson GM, Leckman JF (1998) A double-blind placebo-controlled, crossover trial of an antiandrogen in the treatment of Tourette’s syndrome. Journal of Clinical Psychopharmacology 18: 324–31
Petter T, Richter MA, Sandor P (1998) Clinical features distinguishing patients with Tourette’s syndrome and obsessivecompulsive disorder from patients with obsessive-compulsive disorder without tics. Journal of Clinical Psychiatry 59: 456–459
Pollack MA, Cohen NL, Friedhoff AJ (1977) Gilles de la Tourette’s syndrome. Familial occurrence and precipitation by methylphenidate therapy. Archives of Neurology 34: 630–2
Ratzoni G, Hermesh H, Brandt H, Lauffer M, Muhitz H (1990) Clomipramine efficacy for tics, obsessions and compulsions in Tourette’s syndrome and obsessive-compulsive disorder — a case-study. Biological Psychiatry 27: 95–8
Rauch S, Beer L, Cosgrove GR, Jenike MA (1995) Neurosurgical treatment of Tourette’s syndrome: a critical review. Comprehensive Psychiatry 36: 141–56
Regeur L, Pakkenberg B, Fog R, Pakkenberg H (1986) Clinical features and longterm treatment with pimozide in 65 patients with Gilles de la Tourette’s syndrome. Journal of neurology, Neurosurgery and Psychiatry 49: 791–5
Rickards H, Hartley N, Robertson MM (1997) Seignot’s paper on the treatment of Tourette’s syndrome with haloperidol. History of Psychiatry 7: 433–436
Riddle MA, Hardin MT, King R, Scahill L, Woolston JL (1990) Fluoxetine treatment of children and adolescents with Tourette’s and obsessive compulsive disorders: preliminary clinical experience. Journal of the American Academy of Child and Adolescent Psychiatry 29: 45–8
Robertson MM, Trimble MR, Lees AJ (1988) The psychopathology of the Gilles de la Tourette syndrome: a phenomenological analysis. British Journal of Psychiatry 152: 383–390
Robertson MM (1989) The Gilles de la Tourette syndrome: the current status. British Journal of Psychiatry 154: 147–169
Robertson MM, Trimble MR, Lees AJ (1989) Self-injurious behaviour and the Gilles de la Tourette syndrome: a clinical study and review of the literature. Psychological Medicine 19: 611–625
Robertson MM, Gourdie A (1990) Familial Tourette’s syndrome in a large British pedigree: associated psychopathology, severity and potential for linkage analysis. British Journal of Psychiatry 156: 515–521
Robertson MM, Schneiden V, Lees AJ (1990) Management of Gilles de la Tourette syndrome using sulpiride. Clinical Neuropharmacology 13: 229–35
Robertson MM, Eapen V (1992) The pharmacologic controversy of CNS stimulants in Gilles de la Tourette syndrome. Clinical Neuropharmacology 15: 408–425
Robertson MM, Channon S, Baker J, Flynn D (1993) The psychopathology of Gilles de la Tourette syndrome: a controlled study. British Journal of Psychiatry 162: 114–117
Robertson MM (1994) Annotation: Gilles de la Tourette syndrome — an update. Journal of Child Psychology and Psychiatry 35: 597–611
Robertson MM (1995) The relationship between Gilles de la Tourette syndrome and obsessive compulsive disorder. Journal of Serotonin Research Suppl 11: 49–62
Robertson MM (2000) Tourette syndrome. associated conditions and the complexities of treatment. Brain 123: 425–462
Robertson MM, Scull DA, Eapen V, Trimble MR (1996) Risperidone in the treatment of Tourette syndrome: a retrospective case note study. Journal of Psychopharmacology 10: 317–20
Robertson MM, Banerjee S, Fox-Hiley PJ, Tannock C (1997) Personality disorder and psychopathology in Tourette’s syndrome: a controlled study. British Journal of Psychiatry 171: 283–286
Robertson MM, Baron-Cohen S (1998) Tourette Syndrome: The Facts. Oxford: Oxford University Press
Rosenberg L, Harris JC, Singer HJS (1984) Relationship of the child behavior checklist to an independent measure of psychopathology. Psychological Reports 54: 427–430
Ross MS, Moldofsky H (1978) A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette syndrome. American Journal of Psychiatry 135: 585–7
Sallee FR, Pollock BG, Stiller RL, Stull S, Everett G, Perel JM (1987) Pharmokinetics of pimozide in adults and children with Tourette’s syndrome. Journal of Clinical Pharmacology 27: 776–81
Sallee FR, Nesbitt L, Jackson C, Sine L, Sethuraman G (1997) Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette’s disorder. American Journal of Psychiatry 154: 1057–62
Salmon G, James A, Smith DM (1998) Bullying in schools: self-reported anxiety, depression and self-esteem in secondary school children. British Medical Journal 317: 924–925
Sanberg PR, Fogelson HM, Manderscheid PZ, Parker KW, Norman AB, McConville Bj (1988) Nicotine gum and haloperidol in Tourette’s syndrome. Lancet 1: 592
Sanberg PRK, Shytle RD, Silver AA (1998) Treatment of Tourette’s syndrome with mecamylamine. Lancet 352: 705–6
Sand PL, Carlson C (1973) Failure to establish Control overtics in the Gilles de la Tourette syndrome with behaviour therapy techniques. British Journal of Psychiatry 122: 665–70
Sandor P, Musisi S, Moldofsky H, Lang A (1990) Tourette syndrome: a follow-up study. Journal of Clinical Psychopharmacology 10: 197–199
Sandyk R (1986) Tourette syndrome: successful treatment with clonidine and oxycodone. Journal of Neurology 233: 178–9
Sandyk R, Bamford CR (1987) Estrogen as adjuvant treatment of Tourette syndrome. Pediatric Neurology 3: 122
Sandyk R, Bamford CR, Laguna J (1987) Clomiphene citrate in Tourette syndrome. Postgraduate Medical Journal 63: 510–11
Scahill L, Riddle MA, King RA, Hardin MT, Rasmussen A, Makuch RW, Leckman JF (1997) Fluoxetine has no marked effect on tic symptoms in patients with Tourette’s syndrome: a double-blind placebo-controlled study. Journal of Child and Adolescent Psychiatry 7: 75–85
Scot BL, Jankovic J, Donovan DT (1996) Botulinum toxin injections into vocal cord in the treatment of malignant coprolalia associated with Tourette’s syndrome. Movement Disorders 11: 431–3
Schwabe MJ, Konkol RJ (1989) Treating Tourette syndrome with haloperidol: predictors of success. Wisconsin Medical Journal 88: 23–7
Shapira NA, McConville BJ, Pagnucco ML, Norman AB, Keck PE (1997) Novel use of tramadol hydrochloride in the treatment of Tourette’s syndrome (letter) Journal of Clinical Psychiatry 58: 174–5
Shapiro AK, Shapiro E, Eisenkraft GJ (1983) Treatment of Gilles de la Tourette’s syndrome with pimozide. American Journal of Psychiatry 140: 1183–6
Shapiro AK, Shapiro E, Eisenkraft GJ (1983) Treatment of Gilles de la Tourette’s syndrome with clonidine and neuroleptics. Archives of General Psychiatry 40: 1235–40
Shapiro E, Shapiro AK, Fulop G, Hubbard M, Mandeli J, Nordlie J, Phillips RA (1989) Controlled study of haloperidol, pimozide and place bo for the treatment of Gilles de la Tourette’s syndrome. Archives of General Psychiatry 46: 722–30
Silva RR, Monoz DM, Daniel W, Barickman J, Friedhoff AJ (1996) Causes of haloperidol discontinuation in patients with Tourette’s disorder: management and alternatives. Journal of Clinical Psychiatry 57: 129–35
Silvestri R, Raffaele M, De Domenico P, Tisano A, Lagana A, Di Perri R (1994) Serotoninergic agents in the treatment of Gilles de la Tourette’s syndrome. Acta Neurologica 16: 58–63
Singer HS, Gammon K, Quaskey S (1985) Haloperidol, fluphenazine and clonidine in Tourette syndrome: controversies in treatment. Pediatric Neuroscience 12: 71–4
Singer HS, Brown J, Quaskey S, Rosenberg LA, Mellits ED, Denckla MB (1995) The treatment of attention-deficit hyperactivity disorder in Tourette’s syndrome: a double-blind placebo-controlled study with clonidine and desipramine. Pediatrics 95: 74–81
Spencer T, Biederman J, Kerman K, Steingard R, Wilens T (1993) Desipramine treatment of children with attentiondeficit hyperactivity disorder and tic disorder or Tourette’s syndrome. Journal of the American Academy of Child and Adolescent Psychiatry 32: 354–60
Spencer T, Biederman J, Wilens T, Steingard R, Geist D (1993) Nortriptyline treatment of children with attentiondeficit hyperactivity disorder of the American Academy of Child and Adolescent Psychiatry 32: 205–10
Spencer T, Biederman J, Wilens T (1994) Tricyclic antidepressant treatment of children with ADHD and tic disorders. Journal of the American Academy of Child and Adolescent Psychiatry 33: 1203–4
Spencer T, Biederman J, Harding M, O’Donnell D, Wilens T, Faraone S, Coffey B, Geller D (1998) Disentangling the overlap between Tourette’s disorder and ADHD. Journal of Child Psychology and Psychiatry 39: 1037–1044
Stein DJ, Bouwer C, Hawkridge S, Emsley RA (1997) Risperidone augmentation of serotonin reuptake inhibitors in obsessive-compulsive and related disorders. Journal of Clinical Psychiatry 58: 119–22
Stern JS, Robertson MM (1977) Tics associated with autistic and pervasive developmental disorders. Neurologic Clinics of North America 15: 345–55
Storms L (1985) Massed negative practice as a behavioral treatment for Gilles de la Tourette’s syndrome. American Journal of Psychotherapy 39: 277–81
Sverd J, Gadow KD, Paolicelli LM (1989) Methylphenidate treatment of attention-deficit hyperactivity disorder in boys with Tourette’s syndrome. Journal of the American Academy of Child and Adolescent Psychiatry 28: 574–9
Swedo SE (1995) Case study: a new infection triggered autoimmune subtype of pediatric obsessive-compulsive disorder and Tourette syndrome. Journal of the American Academy of Child and Adolescent Psychiatry 34: 307–11
Swedo SE, Leonard HL, Garvey M, Mittleman B, Allen AJ, Perlmutter S, Dow S, Zamkoff J, Dubbert BK, Lougee L (1998) Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. American Journal of Psychiatry 155: 264–271
Sweet RD, Bruun R, Shapiro AK (1974) Presynaptic catecholamine antagonists as treatment for Tourette syndrome. Effects of alpha methyl para tyrosine and tetrabenazine. Archives of General Psychiatry 31: 857–61
Taylor E, Sergeant J, Doepfner M, Overmeyer S, Möbius H-J, Eisert H-G (1998) Clinical guidelines for hyperkinetic disorder. European Child and Adolescent Psychiatry 7: 184–200
Teoh JI (1974) Gilles de la Tourette’s syndrome: a study of the treatment of six cases by mass negative practice and without haloperidol. Singapore Medical Journal 15: 139–46
Torup E (1962) A follow-up study of children with tics. Acta Pediatrica 51: 261–268
Trimble MR, Whurr R, Brookes G, Robertson MM (1998) Vocal tics in Gilles de la Tourette syndrome treated with Botulinum toxin injections. Movement Disorders 13: 617–9
Uhr SB, Pruitt B, Berger PA, Stahl SM (1986) Case report of four patients with Tourette syndrome treated with piquindone, aD2 receptor antagonist. Journal of Clinical Psychopharmacology 6: 128–30
Vandewalle W, VanderLinden C, Groenewegen HJ, Caemaert J (1999) Stereotactic treatment of Gilles de la Tourette syndrome by high frequency stimulation of thalamus. Lancet 353: 724
Verhulst FC, Akkerhuis GW, Althaus M (1985) Mental health in Dutch children: a cross-cultural comparison. Acta Psychiatrica Scandinavica 72: (Suppl 323)
Voderholzer U, Muller N, Haag C, Riemann D, Straube A (1997) Periodic limb movements during sleep are a frequent finding in patients with Gilles de la Tourette syndrome. Journal of Neurology 244: 521–6
Walkup J, LaBuda MC, Singer HS, Brown J, Riddle MA, Hurko O (1996) Family study and segregation analysis of Tourette syndrome: evidence for a mixed model of inheritance. American Journal of Human Genetics 59: 684–693
Walsh TL, Lavenstein B, Licamele WL, Bronheim S, O’Leary J (1986) Calcium antagonists in the treatment of Tourette’s disorder. American Journal of Psychiatry 143: 1467–8
Wand RR, Fulton WA, Shady GA, Champion LM, Hubka G (1988) Tourette syndrome and medical treatments in Canada. Neuroscience and Biobehavioral Reviews 12: 229–31
Wand RR, Matazow GS, Shady GA, Furer P, Staley D (1993) Tourette syndrome: associated symptoms and most disabling features. Neuroscience and Biobehavioral Reviews 17: 271–275
Weeks RA, Turjanski N, Brooks DJ (1996) Tourette’s syndrome: a disorder of cingulate and orbitofrontal function. Quarterly Journal of Medicine 89: 401–8
Wilson RS, Garron DC, Tanner CM, Klawans HL (1982) Behavior disturbance in children with Tourette Syndrome. In: Friedhoff AJ, Chase TN (Eds) Gilles de la Tourette Syndrome. New York: Raven Press, pp 329–333
Wodrich DL, benjamin E, Lachar D (1997) Tourette’s syndrome and psychopathology in a child psychiatry setting. Journal of the American Academy of Child and Adolescent Psychiatry 36: 1618–1624
World Health Organisation (1992) International Classification of Diseases and Health Related Problems. Tenth Revision. Geneva: World Health Organisation
Wu L, Li H, Kang L (1996) 156 cases of Gilles de la Tourette syndrome treated by acupuncture. Journal of Traditional Chinese Medicine 16: 211–3
Zausmer DM (1954) The treatment of tics in childhood; a review and follow-up study. Archives of Disease in Childhood 29: 537–542
Zohar A, Bruno R (1997) Normative and pathological obsessive-compulsive behavior and ideation in childhood: a question of timing. Journal of Child Psychology and Psychiatry 38: 993–999
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Robertson, M.M., Stern, J.S. Gilles de la Tourette Syndrome: symptomatic treatment based on evidence. European Child & Adolescent Psychiatry 9 (Suppl 1), S60–S75 (2000). https://doi.org/10.1007/s007870070020
Issue Date:
DOI: https://doi.org/10.1007/s007870070020